We are live on ! Find out more
MG

Michael Gelband ExodusPoint Capital Management

AUM $15.5B
1-Year Est. Return 38.81%
 

Michael Gelband is a co-founder of ExodusPoint Capital Management, a multi-strategy hedge fund launched by veterans of larger alternative platforms. The firm pursues diversified strategies across asset classes with a focus on risk-managed absolute returns. Gelband’s firm is followed as part of the newer generation of multi-strategy complexes.

This Fund
S&P 500
This Quarter Est. Return
-2.63%
1 Year Est. Return
+38.81%
3 Year Est. Return
+110.53%
5 Year Est. Return
+124.16%
10 Year Est. Return
–
AUM
$10.5B
AUM Growth
-$1.83B
Cap. Flow
-$1.43B
Cap. Flow %
-13.63%
Top 10 Hldgs %
22.85%
Holding
2,289
New
494
Increased
544
Reduced
594
Closed
654

Top Buys

Rank Stock Value
1
VMW
VMware, Inc
VMW
+$90M
2
XOM icon
ExxonMobil
XOM
+$88.4M
3
QQQ icon
Invesco QQQ Trust
QQQ
+$87.3M
4
NI icon
NiSource
NI
+$81.2M
5
CMS icon
CMS Energy
CMS
+$70.2M

Top Sells

Rank Stock Value
1
GPN icon
Global Payments
GPN
+$356M
2
DUK icon
Duke Energy
DUK
+$72.3M
3
PNW icon
Pinnacle West Capital
PNW
+$61M
4
OXY icon
Occidental Petroleum
OXY
+$59.8M
5
MRO
Marathon Oil Corporation
MRO
+$58.6M

Sector Composition

Rank Sector Weight
1 Healthcare 11.65%
2 Technology 10.24%
3 Utilities 9.2%
4 Industrials 8.85%
5 Energy 8.58%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
HCA icon
76
CALL
HCA Healthcare
HCA
$92.9B
$24.9M 0.24%
+101,200
New +$27.7M
AAPL icon
77
Apple
AAPL
$4.51T
$24.5M 0.23%
143,050
-50,176
-26% -$9.2M
V icon
78
Visa
V
$693B
$24.2M 0.23%
105,325
+37,076
+54% +$8.91M
DHR icon
79
Danaher
DHR
$154B
$24M 0.23%
+109,328
New +$24.4M
DOC icon
80
Healthpeak Properties
DOC
$14.8B
$24M 0.23%
1,308,123
+1,142,704
+691% +$23.5M
LLY icon
81
Eli Lilly
LLY
$1.12T
$23.3M 0.22%
+43,388
New +$22.4M
TMO icon
82
Thermo Fisher Scientific
TMO
$233B
$23.3M 0.22%
45,951
+18,350
+66% +$9.78M
CRM icon
83
Salesforce
CRM
$171B
$23.1M 0.22%
113,941
-46,339
-29% -$10M
CZR icon
84
Caesars Entertainment
CZR
$6.06B
$23.1M 0.22%
497,671
+394,216
+381% +$20.9M
CZR icon
85
CALL
Caesars Entertainment
CZR
$6.06B
$22.9M 0.22%
494,300
+219,900
+80% +$11.7M
MCD icon
86
McDonald's
MCD
$192B
$22.8M 0.22%
86,504
-70,103
-45% -$20M
KEX icon
87
Kirby Corp
KEX
$7.39B
$22M 0.21%
266,270
+33,271
+14% +$2.69M
AMD icon
88
Advanced Micro Devices
AMD
$773B
$22M 0.21%
214,238
-121,844
-36% -$13.2M
AXTA icon
89
Axalta
AXTA
$7.75B
$21.6M 0.21%
804,224
+476,018
+145% +$14M
KVUE icon
90
Kenvue
KVUE
$36.6B
$21M 0.2%
1,047,740
-367,271
-26% -$8.5M
MPC icon
91
Marathon Petroleum
MPC
$101B
$20.8M 0.2%
137,305
+86,707
+171% +$12.1M
VMRK
92
Vivmark Residential
VMRK
$25B
$20.6M 0.2%
351,302
+15,773
+5% +$1.02M
CI icon
93
Cigna
CI
$73.3B
$20.6M 0.2%
71,848
+31,341
+77% +$8.94M
FCNCA icon
94
First Citizens BancShares
FCNCA
$24.7B
$20.5M 0.2%
14,877
+13,323
+857% +$18.3M
AYX
95
DELISTED
Alteryx Inc
AYX
$20.2M 0.19%
537,027
+167,720
+45% +$6.01M
VRT icon
96
Vertiv
VRT
$101B
$20.1M 0.19%
540,090
-335,800
-38% -$11.1M
KO icon
97
Coca-Cola
KO
$392B
$19.8M 0.19%
353,886
+6,701
+2% +$402K
NOV icon
98
NOV
NOV
$7.28B
$19.8M 0.19%
946,387
+639,768
+209% +$12.7M
TTWO icon
99
Take-Two Interactive
TTWO
$44.8B
$19.8M 0.19%
140,869
+28,730
+26% +$4.14M
CVS icon
100
CVS Health
CVS
$119B
$19.7M 0.19%
282,307
+221,704
+366% +$15.7M
2 3
4
5 6

Similar funds

FGP
Freestone Grove Partners San Francisco, California $15.6B AUM 27.39% 1-Year Est. Return
MIFH
Migdal Insurance & Financial Holdings Petach Tikva, Israel $15.6B AUM 71.29% 1-Year Est. Return
GF
Gabelli Funds Rye, New York $15.7B AUM 36.4% 1-Year Est. Return
AIM
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
Impax Asset Management Group
Impax Asset Management Group London, United Kingdom $15.4B AUM 26.43% 1-Year Est. Return
AA
Acorns Advisers Irvine, California $15.3B AUM 18.32% 1-Year Est. Return
OTPPB
Ontario Teachers' Pension Plan Board Toronto, Ontario, Canada $15.8B AUM 1.29% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $15.3B AUM 24.71% 1-Year Est. Return

Michael Gelband's Q3 2023 Portfolio in Review

As of Q3 2023, Michael Gelband held 2,289 positions worth $10.5B, down 15% from $12.3B the previous quarter. Its ten largest holdings account for 23% of the portfolio.

Michael Gelband withdrew a net $1.43B in Q3 2023, closing 654 positions and reducing 594 holdings. Its most notable exit was Pinnacle West Capital, an estimated $61M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 12% of assets, up from 9.1% a quarter earlier, followed by Technology and Utilities.

Against the trend, Michael Gelband opened a new position in ExxonMobil worth $94.8M.

  • Michael Gelband's largest Q3 2023 buy was ExxonMobil: 806,107 shares worth $94.8M.
  • Michael Gelband added most to VMware, Inc in Q3 2023, an estimated $90M increase.
  • Michael Gelband's biggest Q3 2023 reduction was Global Payments, cutting an estimated $356M.
  • Michael Gelband fully exited Pinnacle West Capital in Q3 2023, selling an estimated $61M.
  • Michael Gelband's ten largest holdings make up 23% of its $10.5B portfolio in Q3 2023.
  • Michael Gelband opened 494 new positions and closed 654 in Q3 2023.
  • Michael Gelband's portfolio value fell 15% quarter-over-quarter to $10.5B.

Based on ExodusPoint Capital Management's 13F filing for Q3 2023, filed 13 Nov 2023.